Affinity Asset Advisors’s Vincerx Pharma, Inc. Common Stock VINC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$1.94M Hold
2023
Q1
$1.55M Hold
2022
Q4
$1.52M Hold
2022
Q3
$2.06M Buy
2022
Q2
$1.81M Hold
2022
Q1
$5.5M Buy
2021
Q4
$11.6M Buy
2021
Q3
$16.3M Buy
2021
Q2
$10.9M Buy
2021
Q1
$10.5M Buy
2020
Q4
$8.43M Buy